(Q48007278)

7 February 2018

title

microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus. (English)

1 reference

7 February 2018

1 reference

1

1 reference

7 February 2018

Timothy G. Dinan

series ordinal

3

1 reference

7 February 2018

John F. Cryan

series ordinal

4

1 reference

7 February 2018

author name string

Susan Grenham

series ordinal

2

1 reference

7 February 2018

publication date

20 May 2013

1 reference

7 February 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

7 February 2018

volume

16

1 reference

7 February 2018

issue

8

1 reference

7 February 2018

page(s)

1885-1892

1 reference

7 February 2018

The descriptive epidemiology of commonly occurring mental disorders in the United States

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Rearing experience and biogenic amine activity in infant rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Riluzole normalizes early-life stress-induced visceral hypersensitivity in rats: role of spinal glutamate reuptake mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

ECS-Induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Variations in maternal care in infancy regulate the development of stress reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Glutamatergic modulators: the future of treating mood disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

From monoamines to genomic targets: a paradigm shift for drug discovery in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Early life stress enhances behavioral vulnerability to stress through the activation of REST4-mediated gene transcription in the medial prefrontal cortex of rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Impact of early-life stress, on group III mGlu receptor levels in the rat hippocampus: effects of ketamine, electroconvulsive shock therapy and fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Epigenetic regulation in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Changes in brain MicroRNAs contribute to cholinergic stress reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Prediction of mammalian microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

From synapse to nucleus: novel targets for treating depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

inferred from DOI database lookup

7 January 2021

based on heuristic

5-HT(2B) receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunction

1 reference

https://api.crossref.org/works/10.1017%2FS1461145713000448

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S1461145713000448

1 reference

7 February 2018

PubMed ID

23684180

1 reference

7 February 2018